Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data

[1]  W T Carpenter,et al.  The prediction of outcome in schizophrenia. I. Characteristics of outcome. , 1972, Archives of general psychiatry.

[2]  W T Carpenter,et al.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.

[3]  A. Lehman,et al.  A Quality of Life Interview for the chronically mentally ill. , 1988 .

[4]  J. Addington,et al.  Specificity of the Calgary Depression Scale for schizophrenics , 1994, Schizophrenia Research.

[5]  S. Marder,et al.  The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. , 1997, The Journal of clinical psychiatry.

[6]  Philip D. Harvey,et al.  Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[7]  T. Stroup,et al.  Assessing Clinical and Functional Outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (catie) Schizophrenia Trial Send Reprint Requests to Clinical Outcome Measures: Primary Outcome Clinical and Functional Outcomes Table 1. Catie Schizophrenia Trial Centers' Clinical and Func , 2022 .

[8]  M. Harrow,et al.  Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis. , 2004, Schizophrenia bulletin.

[9]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[10]  N. Andreasen,et al.  Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. , 2005, The American journal of psychiatry.

[11]  R. Munzner,et al.  Regulatory issues , 2005, Alzheimer's & Dementia.

[12]  Brian Kirkpatrick,et al.  The NIMH-MATRICS consensus statement on negative symptoms. , 2006, Schizophrenia bulletin.

[13]  J. Lieberman,et al.  Relationship of cognition and psychopathology to functional impairment in schizophrenia. , 2008, The American journal of psychiatry.

[14]  P. Rocca,et al.  Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.